“…Furthermore, dysregulation of cardiac TREK-1 expression has been observed in patients suffering from atrial fibrillation and heart failure [14,15]. Even though the pharmacological [16,17,18,19,20,21,22] and biophysical [23,24,25,26,27,28] characteristics of hTREK-1 channels have been widely studied, relatively little is known about its posttranslational modifications [29].…”